Not only in AML but also in chronic myeloid leukemia (CML), the downregulation of NKp30 and NKp46 receptors negatively affects the patient survival rate [75]. The gene discussed is NCR3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.